Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Trident Texofab

540726
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Trident Texofab Share price and Fundamental Analysis

View All Details
View All Details
Trident Texofab Limited was originally incorporated as a private limited company with the name 'Trident Texofab Private Limited' on September 05, 2008. Subsequently, the company was converted into public limited Company and the name of the company was changed to 'Trident Texofab Limited' on June 06, 2017.
Company Incorporation2008
ChairmanHardik J Desai
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
291.17
PE Ratio
116.08
Industry P/E
23.8
PEG Ratio
1.6
ROE
5.31%
ROCE
9.06%
ROA
2.5%
Total Debt (Cr)
29.6
Debt to Equity
0.63
Dividend Yield
0%
EPS
1.85
Book Value & P/B
34.84 x 6.16
Face Value
10
Outstanding Shares(Cr)
1.36
Current Ratio
3.44
EV to Sales
2.6

Stock Returns

1 Week+5.09%
1 Month+7.13%
6 Months+32.73%
1 Year+345.54%
3 Years+74.1%
5 Years+652.45%
no_data

No Stocks

Smart Score

1.6
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
May 25

Promoters : 34.53%

FIIs : 0.00%

DIIs : 0.00%

Public : 65.47%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in May 2025 Qtr
Promoter Shareholding Decreased by 6.13% to 34.53% in May 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Trident Texofab Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Trident Texofab Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Trident Texofab Limited was originally incorporated as a private limited company with the name 'Trident Texofab Private Limited' on September 05, 2008. Subsequently, the company was converted into public limited Company and the name of the company was changed to 'Trident Texofab Limited' on June 06, 2017.

The Promoters of the Company are Hardik J. Desai and Chetan C. Jariwala who have an experience of about two decades in textile industry. The wide experience of the Promoters has been instrumental in determining the vision and growth strategies for the Company.

Trident Texofab is a multi-product fabric trading Company and its range includes home furnishing, bedsheets, scarfs, pareos, suiting and shirting and technical textile fabrics, etc. The product portfolio includes finished, unfinished fabrics and value added fabrics. The Company's proficiency lies in understanding the specific requirement of customers and based on which it places the order of its products to manufacturer having requisite manufacturing facilities. The Company supervises the entire manufacturing process including selection of yarn, weaving of cloth till dispatch of the goods to customers place, to assure product quality and customer satisfaction.

Trident Texofab Share Price

Trident Texofab share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Trident Texofab Market Cap

Market capitalization of Trident Texofab indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Trident Texofab is valued compared to its competitors.

Trident Texofab PE Ratio

Trident Texofab PE ratio helps investors understand what is the market value of each stock compared to Trident Texofab 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Trident Texofab PEG Ratio

The PEG ratio of Trident Texofab evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Trident Texofab ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Trident Texofab generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Trident Texofab ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Trident Texofab in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Trident Texofab Total Debt

Total debt of Trident Texofab shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Trident Texofab Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Trident Texofab compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Trident Texofab CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Trident Texofab over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Trident Texofab Technical Analysis

Technical analysis of Trident Texofab helps investors get an insight into when they can enter or exit the stock. Key components of Trident Texofab Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Trident Texofab shares often struggle to rise above due to selling pressure.

Trident Texofab Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Trident Texofab ’s financial health and profitability.

Trident Texofab Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Trident Texofab Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Trident Texofab Financials

The financials of Trident Texofab provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Trident Texofab Profit and Loss Statements

The profit and loss statement of Trident Texofab highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Trident Texofab .

Trident Texofab Balance Sheet

The balance sheet presents a snapshot of Trident Texofab ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Trident Texofab Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App